146 related articles for article (PubMed ID: 20133025)
1. Synthesis and biological activity of n-butylphthalide derivatives.
Wang W; Cha XX; Reiner J; Gao Y; Qiao HL; Shen JX; Chang JB
Eur J Med Chem; 2010 May; 45(5):1941-6. PubMed ID: 20133025
[TBL] [Abstract][Full Text] [Related]
2. Identification of SVM-based classification model, synthesis and evaluation of prenylated flavonoids as vasorelaxant agents.
Dong X; Liu Y; Yan J; Jiang C; Chen J; Liu T; Hu Y
Bioorg Med Chem; 2008 Sep; 16(17):8151-60. PubMed ID: 18678502
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 3-(1H-indol-3-yl)pyrazole-5-carboxylic acid derivatives.
Zhang D; Wang G; Tan C; Xu W; Pei Y; Huo L
Arch Pharm Res; 2011 Mar; 34(3):343-55. PubMed ID: 21547665
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, biological evaluation and structure-activity relationships of new phthalazinedione derivatives with vasorelaxant activity.
Munín J; Quezada E; Cuiñas A; Campos-Toimil M; Uriarte E; Santana L; Viña D
Eur J Med Chem; 2014 Jul; 82():407-17. PubMed ID: 24929291
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of flavonoids as vasorelaxant agents.
Chen Z; Hu Y; Wu H; Jiang H
Bioorg Med Chem Lett; 2004 Aug; 14(15):3949-52. PubMed ID: 15225704
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and 2D-QSAR Study of Active Benzofuran-Based Vasodilators.
Khalifa NM; Srour AM; Abd El-Karim SS; Saleh DO; Al-Omar MA
Molecules; 2017 Oct; 22(11):. PubMed ID: 29072621
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and vasodilative activity of tanshinone IIA derivatives.
Bi YF; Wang ZJ; Guan RF; Ye YT; Chen YY; Zhang YB; Liu HM
Bioorg Med Chem Lett; 2012 Aug; 22(15):5141-3. PubMed ID: 22765898
[TBL] [Abstract][Full Text] [Related]
8. Studies towards the identification of putative bioactive conformation of potent vasodilator arylidene N-acylhydrazone derivatives.
Kümmerle AE; Raimundo JM; Leal CM; da Silva GS; Balliano TL; Pereira MA; de Simone CA; Sudo RT; Zapata-Sudo G; Fraga CA; Barreiro EJ
Eur J Med Chem; 2009 Oct; 44(10):4004-9. PubMed ID: 19500884
[TBL] [Abstract][Full Text] [Related]
9. [Synthesis and vascular relaxing activity of arecoline derivatives coupled with nitric oxide donors].
Huang ST; Huang WL; Zhang HB
Yao Xue Xue Bao; 2006 Jan; 41(1):71-5. PubMed ID: 16683531
[TBL] [Abstract][Full Text] [Related]
10. A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial.
Alvey L; Prado S; Huteau V; Saint-Joanis B; Michel S; Koch M; Cole ST; Tillequin F; Janin YL
Bioorg Med Chem; 2008 Sep; 16(17):8264-72. PubMed ID: 18752967
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of nitric oxide releasing derivatives of 6-amino-3-n-butylphthalide as potential antiplatelet agents.
Wang X; Wang L; Huang Z; Sheng X; Li T; Ji H; Xu J; Zhang Y
Bioorg Med Chem Lett; 2013 Apr; 23(7):1985-8. PubMed ID: 23481646
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of novel hybrid chalcone derivatives as vasorelaxant agents.
Dong X; Du L; Pan Z; Liu T; Yang B; Hu Y
Eur J Med Chem; 2010 Sep; 45(9):3986-92. PubMed ID: 20566231
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis, and biological evaluation of prenylated chalcones as vasorelaxant agents.
Dong X; Chen J; Jiang C; Liu T; Hu Y
Arch Pharm (Weinheim); 2009 Jul; 342(7):428-32. PubMed ID: 19544479
[TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of small molecule RhoA inhibitors: a new promising therapy for cardiovascular diseases?
Deng J; Feng E; Ma S; Zhang Y; Liu X; Li H; Huang H; Zhu J; Zhu W; Shen X; Miao L; Liu H; Jiang H; Li J
J Med Chem; 2011 Jul; 54(13):4508-22. PubMed ID: 21615130
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, vasorelaxant activity and 2D-QSAR study of some novel pyridazine derivatives.
George RF; Saleh DO
Eur J Med Chem; 2016 Jan; 108():663-673. PubMed ID: 26735908
[TBL] [Abstract][Full Text] [Related]
16. Benzofuran-morpholinomethyl-pyrazoline hybrids as a new class of vasorelaxant agents: synthesis and quantitative structure-activity relationship study.
Hassan GS; Rahman DE; Abdel Saleh DO; Abdel Jaleel GA
Chem Pharm Bull (Tokyo); 2014; 62(12):1238-51. PubMed ID: 25450632
[TBL] [Abstract][Full Text] [Related]
17. New 1,4-dihydropyridines conjugated to furoxanyl moieties, endowed with both nitric oxide-like and calcium channel antagonist vasodilator activities.
Di Stilo A; Visentin S; Cena C; Gasco AM; Ermondi G; Gasco A
J Med Chem; 1998 Dec; 41(27):5393-401. PubMed ID: 9876109
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and vasorelaxation action of flavonoids].
Chen ZW; Hu YZ; Wu HH; Jiang HD
Yao Xue Xue Bao; 2005 Nov; 40(11):1001-7. PubMed ID: 16499084
[TBL] [Abstract][Full Text] [Related]
19. Second generation of alpha-tocopherol analogs-nitric oxide donors: Synthesis, physicochemical, and biological characterization.
López GV; Blanco F; Hernández P; Ferreira A; Piro OE; Batthyány C; González M; Rubbo H; Cerecetto H
Bioorg Med Chem; 2007 Sep; 15(18):6262-72. PubMed ID: 17627828
[TBL] [Abstract][Full Text] [Related]
20. Understanding the cardioprotective effects of flavonols: discovery of relaxant flavonols without antioxidant activity.
Qin CX; Chen X; Hughes RA; Williams SJ; Woodman OL
J Med Chem; 2008 Mar; 51(6):1874-84. PubMed ID: 18307286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
